Learn more

HYUNDAI PHARM CO LTD

Overview
  • Total Patents
    127
  • GoodIP Patent Rank
    22,094
  • Filing trend
    ⇧ 100.0%
About

HYUNDAI PHARM CO LTD has a total of 127 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are EPITHERAPEUTICS APS, TAKEDA SCHERING PLOUGH ANIMAL and VIROPHARMA INC.

Patent filings per year

Chart showing HYUNDAI PHARM CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lee Han Kyu 35
#2 Yang Jin 33
#3 Kim Jae Hyun 33
#4 Son Chang Mo 33
#5 Lee Kyu Hwan 33
#6 Rhee Jae Keol 33
#7 Kim Jin Woong 32
#8 Rhee Jaekeol 21
#9 Choi Hyung-Ho 21
#10 Kim Daehoon 18

Latest patents

Publication Filing date Title
KR20200138078A Novel polymorphs of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative
WO2019108046A1 Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative
KR20170053118A Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
KR101741956B1 Novel compound, process for the preparation thereof and pharmaceutical composition comprising the same
CN107205908A What stability was improved educates hair, hair care or hair tonic composition for promoting containing melatonin
US2017296539A1 Composite preparation, containing novel 3-(4--(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases
KR20160136634A Liquid medicament container
WO2015167309A1 Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
KR20150126564A Novel cyclohexene derivatives, preparation method thereof and pharmaceutical composition for prevention or treatment of the metabolic diseases containing the same as an active ingredient
KR20140126248A Novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative, preparation method thereof, and pharmaceutical composition for use in preventing or treating metabolic diseases containing the same as an active ingredient
WO2014163338A1 Composition for external use preparation with improved transdermal permeability
US2016058723A1 Composition for external use preparation with improved transdermal permeability
KR20150110901A Compounds that binding with PPARG(Peroxisome Proliferator Activated Receptor-Gamma) but not act as an agonist and pharmaceutical composition for diseases related with PPARG containing the same as an active ingredient
KR101506627B1 Sustained-release pharmaceutical composition comprising acebrophylline and a hydrophilic material
KR101506626B1 Sustained-release pharmaceutical composition comprising acebrophylline and a hydrophobic material
KR20140015199A Composition for improving condition of hair and scalp comprising natural extracts
WO2014017804A1 Composition comprising natural extracts as active ingredients for improving condition of hair and scalp, and method for preparing same
KR20140118531A Compositions Comprising Extract from Litchi chinensis Sonn. and Artemisiae Iwayomogii Herba. for Preventing, Improving or Treating Obesity
KR20140063919A Novel piperazine derivatives, pharmaceutically acceptable salts thereof or optical isomer thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of the metabolic diseases containing the same as an active ingredient
KR20140025804A Substituted piperidine derivatives and methods for manufacturing the same